Article Abstract:
Bayer AG has agreed to pay $14 million to settle claims by US federal and state prosecutors that the company mispresented wholesale prices of certain drugs to gain market advantage. As part of the settlement of the drug-pricing case, the German drugmaker also promised to report to states what it actually charges for prescription drug products, rather than falsely inflate wholesale prices. With such policy, prosecutors believe that doctors will not anymore be able to overcharge state health programs for drugs.
User Contributions:
Comment about this article or add new information about this topic:
Article Abstract:
The attorney general of Texas is seeking $79 million in damages from three drug companies for allegedly cheating the state's Medicaid program by inflating the prices of respiratory drugs. These companies are Warrick Pharmaceuticals, Dey Laboratories and Roxane Laboratories. Congress is also investigating executives of SmithKline Beecham, which declined to turn over five documents and plan to investigate Glaxo Welcome officials afterwards.
User Contributions:
Comment about this article or add new information about this topic:
Article Abstract:
Government investigators have discovered documents showing that drug companies deliberately manipulate prices so that doctors can overcharge Medicare and promote this profit-making strategy to physicians. These documents, which were released by the House Commerce Committee on Sep 26, 2000, also suggest that this manipulative practice of drug companies may cost government health programs and patients $1 billion a year.
User Contributions:
Comment about this article or add new information about this topic: